Welcome to our dedicated page for AKANDA news (Ticker: AKAN), a resource for investors and traders seeking the latest updates and insights on AKANDA stock.
Akanda Corp (AKAN) delivers medical cannabis solutions through regulated cultivation and innovative technology integration. This news hub provides investors and stakeholders with essential updates on the company's operations across three core segments: EU-GMP certified cannabis production, UK distribution via CanMart, and corporate strategy implementation.
Access timely press releases covering earnings reports, regulatory compliance milestones, partnership announcements, and technological advancements including blockchain supply chain initiatives and AI-driven operational improvements. Our curated collection ensures transparent tracking of AKAN's progress in pharmaceutical-grade cannabis production and international market expansion.
Bookmark this page for verified updates on cultivation facility developments, distribution network growth, and corporate governance changes. All content undergoes rigorous verification to maintain compliance with financial disclosure standards and medical cannabis regulations.
Akanda Corp. (NASDAQ: AKAN) announced on March 27, 2023, that it has regained compliance with the Nasdaq minimum bid price requirement after a notification letter indicated it had met the criteria. The company had previously received a non-compliance notice on September 27, 2022, due to its stock price falling below $1.00 for 30 consecutive business days. Following a compliance period of 180 days, Akanda's shares have maintained a closing bid price of at least $1.00 for the last 12 business days, thus closing the matter with Nasdaq.
FAQ
What is the current stock price of AKANDA (AKAN)?
What is the market cap of AKANDA (AKAN)?
